That's fair. Here's my summary.

The paper, surveying several major reent studies, notes that for prostate cancer that

1. has already metastasised when it's first discovered and

2. still responds to hormone therapy,

best practice seems to be to combine ADT and something like one of the -lutamides right from the start (doublet therapy)

If there are lots of metastases, it often makes sense to add chemotherapy to those (triplet therapy).

If there are only a tiny number of metastases, chemo doesn't show a benefit at this point, but it's helpful to radiate the individual metastases.